Fed Decriminalization of Cannabis Could Spark New Pot Stock Boom
With Democrats now controlling both houses of Congress and the executive branch, cannabis decriminalization on the federal level could be months away. This could result in established Washington State weed companies being able to market across state lines -- setting off a bidding war for quality stocks at reasonable prices.
Get All the Details on #1Interstate Cannabis

SN Insider Trading (Smith & Nephew)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): £3,908.70
Insider Selling (Last 12 Months): GBX 0

Smith & Nephew Insider Trading History Chart

Smith & Nephew Share Price & Price History

GBX 1,528.50
▼ -29 (-1.86%)
As of 06/18/2021 01:00 AM ET
Days: 30 | 90 | 365
Facebook Billionaire Investing in a Shocking New Industry
Peter Thiel, the billionaire investor behind Facebook, PayPal, and eBay, has a new darling industry in his sights. And he's betting a massive $210 million on its success. That's not pocket change.
And today, you could get in on the ground floor

Smith & Nephew Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/24/2020Virginia BottomleyInsiderBuy258GBX 1,515£3,908.70
5/14/2020Roland DiggelmannInsiderBuy2,125GBX 1,510£32,087.50
3/31/2020Roland DiggelmannInsiderBuy6,000GBX 1,424£85,440
3/9/2020Graham BakerInsiderSell3,565GBX 1,576£56,184.40
8/23/2019Virginia BottomleyInsiderBuy201GBX 1,939£3,897.39
5/3/2019Roland DiggelmannInsiderBuy1,540GBX 1,532£23,592.80
3/7/2019Susan SwabeyInsiderSell1,097GBX 1,453£15,939.41
8/23/2018Erik EngstromInsiderBuy249GBX 1,380£3,436.20
8/2/2018Graham BakerInsiderBuy19GBX 1,331£252.89
See Full Table
Smith & Nephew logo
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.
Read More on Smith & Nephew

Today's Range

Now: GBX 1,528.50
1,528.50
1,567

50 Day Range

MA: GBX 1,513.19
1,400
1,583

52 Week Range

Now: GBX 1,528.50
1,317
1,681.50

Volume

3,705,598 shs

Average Volume

343,671 shs

Market Capitalization

£13.44 billion

P/E Ratio

41.99

Dividend Yield

1.79%

Beta

N/A

Who are the company insiders with the largest holdings of Smith & Nephew?

Smith & Nephew's top insider investors include:
  1. Graham Baker (Insider)
  2. Roland Diggelmann (Insider)
  3. Virginia Bottomley (Insider)
Fed Decriminalization of Cannabis Could Spark New Pot Stock Boom
With Democrats now controlling both houses of Congress and the executive branch, cannabis decriminalization on the federal level could be months away. This could result in established Washington State weed companies being able to market across state lines -- setting off a bidding war for quality stocks at reasonable prices.
Get All the Details on #1Interstate Cannabis